Clinical Trial Update: Alemtuzumab Induction in Islet Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating alemtuzumab as induction therapy in islet transplantation for Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CAMPATH (ALEMTUZUMAB)

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED